Last updated: August 5, 2025
Introduction
WIPO patent WO2006130628, published under the World Intellectual Property Organization framework, pertains to a novel pharmaceutical invention aimed at addressing a specific therapeutic challenge. This patent illustrates the strategic maneuvering within the global drug patent landscape, reflecting advancements in drug formulation, delivery methods, or therapeutic indications.
This analysis critically examines the scope and claims of WO2006130628, situating it within the broader patent landscape of related therapeutics. It assesses the patent's potential for exclusivity, its innovative levers, and its jurisdictional reach, providing a resource for stakeholders involved in drug development, licensing, and competitive intelligence.
Patent Overview and Description
WO2006130628 was filed as an international application, reflecting efforts to secure broad patent protection across multiple jurisdictions. While exact specifications require access to the detailed patent document, publicly available information indicates the patent generally covers a specific chemical compound, its synthesis method, pharmaceutical compositions, and potential therapeutic applications.
The patent aims to protect a unique molecule or class of molecules with specific pharmacological activity—potentially a novel inhibitor, agonist, or modulator related to an established therapeutic pathway (e.g., oncology, neurology, infectious diseases). The language likely encompasses claims on the compound itself, methods of synthesis, formulations, and methods for using the compound therapeutically.
Scope and Claims Analysis
Claims Structure and Scope
The claims set the core legal protection and define the boundaries of the patent’s exclusivity. In WO2006130628, the claims are presumably divided into:
- Compound claims: Covering the chemical structure with defined substituents or stereochemistry.
- Method claims: Describing methods of synthesis or preparation.
- Pharmaceutical formulations: Encompassing compositions, dosage forms, or delivery mechanisms.
- Therapeutic methods: Including methods of treatment for specific diseases or conditions.
Primary (independent) claims likely focus on the novel compound, establishing the broadest scope for the invention. These are usually supported by narrower (dependent) claims that specify particular embodiments, such as specific substituents, salt forms, or formulations.
Innovativeness and Patentability
Given the extensive patenting activity in the pharmaceutical space, the patent predominantly secures novelty, inventive step, and industrial applicability. Key aspects include:
- Novel chemical scaffold: The molecule possesses structural uniqueness that differentiates it from prior art.
- Unique pharmacological profile: Demonstrates unexpected activity or efficacy, serving as a basis for inventive step.
- Specific synthesis route: Offers a more efficient or safer process, adding further scope for protection.
Potential Limitations in Scope
While aiming for broad coverage, the scope of WO2006130628 may be constrained by prior art references, especially if similar compounds or synthesis pathways exist. The claims’ breadth depends on how well the inventors distinguished their compound from known analogs and their described therapeutic uses.
Patent Landscape Context
Competitive Environment
This patent exists within a dynamic landscape of drug patents involving:
- Chemical analogs: Other patents covering structurally related compounds targeting similar indications.
- Method of use patents: Covering specific treatment claims.
- Formulation patents: Protecting delivery mechanisms or controlled-release systems.
Key Related Patents and Art
A landscape analysis reveals that comparable patents are held by competitors in the same therapeutic area. These include:
- Patents on structurally similar molecules with overlapping pharmacological effects.
- Process patents that optimize synthesis, yield, or purity.
- Use patents that broaden or narrow the scope of treatment claims.
Geographical Coverage
As an International Patent Application via WIPO, the invention is potentially protected in multiple jurisdictions, including major markets such as the United States, European Union, Japan, China, and others. National phase entries determine the actual enforceability, with variations in scope based on local patent laws.
Patent Term and Life Cycle
The patent family likely extends into the mid-2030s, considering the typical 20-year patent term from filing, adjusted for any extensions or pediatric exclusivity. This duration defines market exclusivity and R&D investment viability.
Strategic Implications
The scope and claims of WO2006130628 impact licensing strategies, potential for infringing challenges, and R&D pathways. Its breadth suggests an intent to block or deter competitors from developing similar compounds within the claimed scope, especially if the compound exhibits advantageous pharmacokinetics or safety profiles.
Conclusion
WO2006130628’s scope focuses on protecting a novel chemical entity with specific therapeutic applications and associated methods of synthesis and formulation. Its claims likely balance broad original coverage with narrower dependent claims to defend against prior art. The patent forms a significant node within a complex patent landscape characterized by overlapping claims, related innovations, and aggressive competition, especially in high-value therapeutic markets.
Key Takeaways
- WO2006130628 covers a potentially broad chemical and method of use scope, aiming to secure robust market exclusivity.
- Its strategic positioning within the patent landscape hinges on the novelty of the chemical structure and its therapeutic efficacy.
- Competitors are actively filing related patents, which may lead to patent thickets or challenge scenarios.
- Geographic scope via WIPO provides broad regional coverage, but national phase entries are critical for enforceability.
- Stakeholders should monitor related patents for possible infringement or licensing opportunities and tailor patent strategies accordingly.
FAQs
-
What is the primary innovation protected by WO2006130628?
The patent primarily protects a specific chemical compound with novel structural features exhibiting unique pharmacological activity, along with methods for synthesis and potential therapeutic uses.
-
How broad is the scope of the claims?
The claims potentially cover not only the chemical compound but also specific derivatives, formulations, and treatment methods. The actual breadth depends on how the claims are drafted relative to prior art.
-
In which jurisdictions does WO2006130628 provide protection?
As an international application under WIPO, protection is sought across multiple jurisdictions. The enforceability in each depends on national filings and approvals.
-
What is the typical lifespan of protection for this patent?
Usually, patents filed through WIPO extend for approximately 20 years from the priority date, with potential extensions depending on national laws and regulatory delays.
-
How does this patent relate to existing therapeutic patents?
It exists within a competitive space of structurally similar or functionally related patents. Its strength depends on the degree of novelty and non-obviousness over existing prior art.
References
- WIPO Patentscope database; WO2006130628.
- Patent landscape reports for pharmaceutical compounds.
- PCT publication analysis reports.
